108 related articles for article (PubMed ID: 29698062)
1. Targeted deletion of T-cell S1P receptor 1 ameliorates cardiac fibrosis in streptozotocin-induced diabetic mice.
Abdullah CS; Jin ZQ
FASEB J; 2018 Oct; 32(10):5426-5435. PubMed ID: 29698062
[TBL] [Abstract][Full Text] [Related]
2. Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy.
Abdullah CS; Li Z; Wang X; Jin ZQ
Int Immunopharmacol; 2016 Oct; 39():251-264. PubMed ID: 27494688
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PKC-θ preserves cardiac function and reduces fibrosis in streptozotocin-induced diabetic cardiomyopathy.
Li Z; Abdullah CS; Jin ZQ
Br J Pharmacol; 2014 Jun; 171(11):2913-24. PubMed ID: 24641494
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine 1-phosphate receptor-1 in cardiomyocytes is required for normal cardiac development.
Clay H; Wilsbacher LD; Wilson SJ; Duong DN; McDonald M; Lam I; Park KE; Chun J; Coughlin SR
Dev Biol; 2016 Oct; 418(1):157-165. PubMed ID: 27333774
[TBL] [Abstract][Full Text] [Related]
5. Ablation of interleukin-17 alleviated cardiac interstitial fibrosis and improved cardiac function via inhibiting long non-coding RNA-AK081284 in diabetic mice.
Zhang Y; Zhang YY; Li TT; Wang J; Jiang Y; Zhao Y; Jin XX; Xue GL; Yang Y; Zhang XF; Sun YY; Zhang ZR; Gao X; Du ZM; Lu YJ; Yang BF; Pan ZW
J Mol Cell Cardiol; 2018 Feb; 115():64-72. PubMed ID: 29305939
[TBL] [Abstract][Full Text] [Related]
6. Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart.
Myers RB; Fomovsky GM; Lee S; Tan M; Wang BF; Patwari P; Yoshioka J
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1748-59. PubMed ID: 27037370
[TBL] [Abstract][Full Text] [Related]
7. Type 1 sphingosine 1-phosphate G protein-coupled receptor signaling of lymphocyte functions requires sulfation of its extracellular amino-terminal tyrosines.
Fieger CB; Huang MC; Van Brocklyn JR; Goetzl EJ
FASEB J; 2005 Nov; 19(13):1926-8. PubMed ID: 16148028
[TBL] [Abstract][Full Text] [Related]
8. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.
Galvani S; Sanson M; Blaho VA; Swendeman SL; Obinata H; Conger H; Dahlbäck B; Kono M; Proia RL; Smith JD; Hla T
Sci Signal; 2015 Aug; 8(389):ra79. PubMed ID: 26268607
[TBL] [Abstract][Full Text] [Related]
9. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-Phosphate Receptor 1 Is Involved in Non-Obese Diabetic Mouse Thymocyte Migration Disorders.
Lemos JP; Smaniotto S; Messias CV; Moreira OC; Cotta-de-Almeida V; Dardenne M; Savino W; Mendes-da-Cruz DA
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757216
[TBL] [Abstract][Full Text] [Related]
11. Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6.
Ohkura SI; Usui S; Takashima SI; Takuwa N; Yoshioka K; Okamoto Y; Inagaki Y; Sugimoto N; Kitano T; Takamura M; Wada T; Kaneko S; Takuwa Y
PLoS One; 2017; 12(8):e0182329. PubMed ID: 28771545
[TBL] [Abstract][Full Text] [Related]
12. Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways.
Zhang Y; Wang JH; Zhang YY; Wang YZ; Wang J; Zhao Y; Jin XX; Xue GL; Li PH; Sun YL; Huang QH; Song XT; Zhang ZR; Gao X; Yang BF; Du ZM; Pan ZW
Sci Rep; 2016 Mar; 6():23010. PubMed ID: 26972749
[TBL] [Abstract][Full Text] [Related]
13. miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes.
Feng B; Chen S; Gordon AD; Chakrabarti S
J Mol Cell Cardiol; 2017 Apr; 105():70-76. PubMed ID: 28279663
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice.
Wu H; Li GN; Xie J; Li R; Chen QH; Chen JZ; Wei ZH; Kang LN; Xu B
BMC Cardiovasc Disord; 2016 Jan; 16():5. PubMed ID: 26750922
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling.
Gatfield J; Monnier L; Studer R; Bolli MH; Steiner B; Nayler O
Cell Signal; 2014 Jul; 26(7):1576-88. PubMed ID: 24704119
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69.
Srinivasan S; Bolick DT; Lukashev D; Lappas C; Sitkovsky M; Lynch KR; Hedrick CC
Diabetes; 2008 Feb; 57(2):484-93. PubMed ID: 18003758
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-Phosphate Receptor 1 Regulates Cardiac Function by Modulating Ca2+ Sensitivity and Na+/H+ Exchange and Mediates Protection by Ischemic Preconditioning.
Keul P; van Borren MM; Ghanem A; Müller FU; Baartscheer A; Verkerk AO; Stümpel F; Schulte JS; Hamdani N; Linke WA; van Loenen P; Matus M; Schmitz W; Stypmann J; Tiemann K; Ravesloot JH; Alewijnse AE; Hermann S; Spijkers LJ; Hiller KH; Herr D; Heusch G; Schäfers M; Peters SL; Chun J; Levkau B
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207969
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F
Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486
[TBL] [Abstract][Full Text] [Related]
19. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 Activation.
Messias CV; Santana-Van-Vliet E; Lemos JP; Moreira OC; Cotta-de-Almeida V; Savino W; Mendes-da-Cruz DA
PLoS One; 2016; 11(1):e0148137. PubMed ID: 26824863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
